1) Odontogenic and maxilofacial bone tumours. In: El-Naggar AK,
Chan JKC, Grandis JR, Takata T, Slootweg P, editors. WHO
classification of Head and Neck Tumours. 4th ed. Lyon: IARC;
2017.205-60.
2) Wright JM, Vered M. Update from the 4th Edition of the World
Health Organization Classification of Head and Neck Tumours:
Odontogenic and maxillofacial bone tumors. Head Neck Pathol.
2017;11:68-77.
3) Odontogenic tumors. In: Barnes L, Eveson J, Reichart P,
Sidransky D, editors. World Health Organization classification.
Pathology and Genetics of Head and Neck Tumors. 3rd ed. Lyon:
IARC Press; 2005.283-327.
4) B runner P, Bihl M, Jundt G, Baumhoer D, Hoeller S. BRAF
p.V600E mutations are not unique to ameloblastoma and
are shared by other odontogenic tumors with ameloblastic
morphology. Oral Oncol. 2015;51:e77-8.
5) Bologna-Molina R, Mosqueda-Taylor A, Molina-Frechero N,
Mori-Estevez AD, Sán- chez-Acuña G. Comparison of the value
of PCNA and Ki-67 as markers of cell proliferation in ameloblastic
tumors. Med Oral Patol Oral Cir Bucal. 2013;18:e174-9.
6) Lei Y, Jaradat JM, Owosho A, Adebiyi KE, Lybrand KS, Neville
BW, Müller S, Bilodeau EA. Evaluation of SOX2 as a potential
marker for ameloblastic carcinoma. Oral Surg Oral Med Oral
Pathol Oral Radiol. 2014;117:608-16.e1.
7) Moro A, Foresta E, Gasparini G, Pelo S, Forcione M, Cristallini
EG, Toraldo M, Lorenzo C, Falchi M, Saponaro G. Ameloblastic
carcinoma of the maxilla: A case report and an updated review of
the literature. Oncol Lett. 2016;12:4339-50.
8) Bodner L, Manor E, Shear M, van der Waal I. Primary
intraosseous squamous cell carcinoma arising in an odontogenic
cyst: A clinicopathologic analysis of 116 reported cases. J Oral
Pathol Med. 2011;40:733-8.
9) Wenguang X, Hao S, Xiaofeng Q, Zhiyong W, Yufeng W,
Qingang H, Wei H. Prognostic Factors of Primary Intraosseous
Squamous Cell Carcinoma (PIOSCC): A retrospective review.
PLoS One. 2016;11:e0153646.
10) Shinoda T, Iwata H, Nakamura A, Ohkubo T, Yoshimi N, Sugie
S, Tanaka T, Kato K. Cytologic appearance of carcinosarcoma
(malignant ameloblastoma and fibrosarcoma) of the maxilla. A
case report. Acta Cytol. 1992;36:132-6.
11) Chikosi R, Segall N, Augusto P, Freedman P. Odontogenic
carcinosarcoma: Case report and literature review. J Oral
Maxillofac Surg. 2011;69:1501-7.
12) Koutlas IG, Allen CM, Warnock GR, Manivel JC. Sclerosing
odontogenic carcinoma: A previously unreported variant of
a locally aggressive odontogenic neoplasm without apparent
metastatic potential. Am J Surg Pathol. 2008;39:1613-19.
13) Irié T, Ogawa I, Takata T, Toyosawa S, Saito N, Akiba M, Isobe
T, Hokazono C, Tachikawa T, Suzuki Y. Sclerosing odontogenic
carcinoma with benign fibro-oseous lesion of the mandible: An
extremely rare case report. Pathol Int. 2010;60:694-700.
14) Tan SH, Yeo JF, Kheem Pang BN, Petersson F. An intraosseous
sclerosing odontogenic tumor predominantly composed of
epithelial cells: Relation to (so-called) sclero- sing odontogenic
carcinoma and epithelial-rich central odontogenic fibroma. Oral
Surg Oral Med Oral Pathol Oral Radiol. 2014;118:e119-25.
15) Bilodeau EA, Weinreb I, Antonescu CR, Zhang L, Dacic S, Muller
S, Barker B, Seethala RR. Clear cell odontogenic carcinomas show
EWSR1 rearrangaments: A noval finding and a biological link to
salivary clear cell carcinomas. Am J Surg Pathol. 2013;37:1001-5.
16) Yancoskie AE, Sreekantaiah C, Jacob J, Rosenberg A, Edelman M,
Antonescu CR, Fantasia JE. EWSR1 and ATF1 rearrangements
in clear cell odontogenic carcinoma: Presentation of a case. Oral
Surg Oral Med Oral Pathol Oral Radiol. 2014;118:e115-8.
17) Antonescu CR, Katabi N, Zhang L, Sung YS, Seethala RR, Jordan
RC, Perez-Ordoñez B, Have C, Asa SL, Leong IT, Bradley G, Klieb
H, Weinreb I. EWSR1-ATF1 fusion is a novel and consistent
finding in hyalinizing clear cell-carcinoma of salivary gland.
Genes Chromosomes Cancer. 2011;50:559-70.
18) Bilodeau ES, Hoschar AP, Barnes EL, Hunt JL, Seethala RR.
Clear cell carcinoma and clear cell odontogenic carcinoma: A
comparative clinicopathological and immunohistochemical
study. Head Neck Pathol. 2011;5:101-7.
19) Ledesma-Montes C, Gorlin RJ, Shear M, Prae Torius F,
Mosqueda-Taylor A, Altini M, Unni K, Paes de Almeida O,
Carlos-Bregni R, Romero de León E, Phillips V, Delgado-Azañero
W, Meneses-García A. International collaborative study on ghost
cell odontogenic tumours: Calcifying cystic odontogenic tumour,
dentinogenic ghost cell tumour and ghost cell odontogenic
carcinoma. J Oral Pathol Med. 2008;37:302-8.
20) Del Corso G, Tardio ML, Gissi DB, Marchetti C, Montebugnoli L,
Tarsitano A. Ki- 67 and p53 expression in ghost cell odontogenic
carcinoma: A case report and literature review. Oral Maxillofac
Surg. 2015;19:85-9.
21) Bose P, Pleasance ED, Jones M, Shen Y, Ch’ng C, Reisle C,
Schein JE, Mungall AJ, Moore R, Ma Y, Sheffield BS, Thomson
T, Rasmussen S, Ng T, Yip S, Lee CW, Ho C, Laskin J, Marra MA,
Jones SJ. Integrative genomic analysis of ghost cell odontogenic
carcinoma. Oral Oncol. 2015;51:e71-5.
22) Chikosi R, Segall N, Augusto P, Freedman P. Odontogenic
carcinosarcoma: Case, report and literature review. J Oral
Maxillofac Surg. 2011;69:1501-7.
23) DeLair D, Bejarano PA, Peleg M, El-Mofty SK. Ameloblastic
carcinosarcoma arising in ameloblastic fibroma of the mandible:
A case report and review of literature. Oral Surg Oral Med Oral
Radiol Endod. 2007;103:516-20.
24) Lai J, Blanas N, Higgins K, Klieb H. Ameloblastic fibrosarcoma:
Report of a case, study of immunophenotype, and comprehensive
review of the literature. J Oral Maxillofac Surg. 2012;70:2007-12.
25) Williams MD, Hanna EY, El-Naggar AK. Anaplastic ameloblastic
fibrosarcoma arising from recurrent ameloblastic fibroma:
Restricted molecular abnormalities of certain genes to the
malignant transformation. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 2007;104:72-5.
26) Hertog D, Bloemena E, Aartman IH, van-der-Waal I.
Histopathology of ameloblastoma of the jaws; some critical
observations based on a 40 years single institution experience.
Med Oral Patol Oral Cir Bucal. 2012;17:e76-82.
27) Sun ZJ, Wu YR, Cheng N, Zwahlen RA, Zhao YF. Desmoplastic
ameloblastoma - A review. Oral Oncol. 2009;45:752-9.
28) Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L,
Lim MS, Elenitoba-Johnson KS, Betz BL. Activating FGFR2-
RAS-BRAF mutations in ameloblastoma. Clin Cancer Res.
2014;20:5517-26.
29) Diniz MG, Gomes CC, Guimarães BV, Castro WH, Lacerda
JC, Cardoso SV, de Faria PR, Dias FL, Eisenberg AL, Loyola
AM, Gomez RS. Assessment of BRAFV600E and SMOF412E
mutations in epithelial odonto- genic tumours. Tumour Biol.
2015;36:5649-53.
30) Kurppa KJ, Catón J, Morgan PR, Ristimäki A, Ruhin B, Kellokoski
J, Elenius K, Heikinheimo K. High frequency of BRAF V600E
mutations in ameloblastoma. J Pathol. 2014;232:492-8.
31) Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L,
Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S, Odegaard
JI, Sugiyama T, Koyota S, Rubin BP, Troxell ML, Pelham RJ,
Zehnder JL, Beachy PA, Pollack JR, West RB. Identification of
recurrent SMO and BRAF mutations in ameloblastomas. Nat
Genet. 2014;46:722-5.
32) B rown NA, Betz BL. Ameloblastoma: A review of recent
molecular pathogenetic discoveries. Biomark Cancer. 2015;7:19-24.
33) Li TJ, Kitano M, Arimura K, Sugihara K. Recurrence of unicystic
ameloblastoma: A case report and review of the literature. Arch
Pathol Lab Med. 1998;122:371-4.
34) Pereira NB, Pereira KM, Coura BP, Diniz MG, de Castro WH,
Gomes CC, Gomez RS. BRAFV600E mutation in the diagnosis
of unicystic ameloblastoma. J Oral Pathol Med. 2016;45:780-5.
35) Smullin SE, Faquin W, Susarla SM, Kaban LB. Peripheral
desmoplastic ameloblastoma: Report of a case and literature
review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2008;105:37-40.
36) Rizzitelli A, Smoll NR, Chae MP, Rozen WM, Hunter-Smith
DJ. Incidence and overall survival of malignant ameloblastoma.
PLoS One. 2015;10:e0117789.
37) Siar CH, Nakano K, Ng KH, Tomida M, Nagatsuka H, Kawakami
T. Squamous odontogenic tumor of the mandible: A case report
demonstrating immunoexpression of Notch1, 3, 4, Jagged1 and
Delta1. Eur J Med Res. 2010;15:180-4.
38) Leider AS, Jonker LA, Cook HE. Multicentric familial
squamous odontogenic tumor. Oral Surg Oral Med Oral Pathol.
1989;68:175- 81.
39) Murphy CL, Kestler DP, Foster JS, Wang S, Macy SD, Kennel
SJ, Carlson ER, Hudson J, Weiss DT, Solomon A. Odontogenic
ameloblast-associated protein nature of the amyloid found in
calcifying epithelial odontogenic tumors and unerupted tooth
follicles. Amyloid. 2008;15:89-95.
40) Solomon A, Murphy CL, Weaver K, Weiss DT, Hrncic R,
Eulitz M, Donnell RL, Sletten K, Westermark G, Westermark P.
Calcifying epithelial odontogenic (Pindborg) tumor-associated
amyloid consists of a novel human protein. J Lab Clin Med.
2003;142:348-55.
41) Peacock ZS, Cox D, Schmidt BL. Involvement of PTCH1
mutations in the calcifying epithelial odontogenic tumor. Oral
Oncol. 2010;46:387-92.
42) Crivelini MM, Felipini RC, Miyahara GI, de Sousa SC.
Expression of odontogenic ameloblast-associated protein,
amelotin, ameloblastin, and amelogenin in odontogenic tumors:
Immunohistochemical analysis and pathogenetic considerations.
J Oral Pathol Med. 2012;41:272-80.
43) Karathanasi V, Tosios KI, Nikitakis NG, Piperi E, Koutlas I,
Trimis G, Sklavounou A.TGF-β1, Smad-2/-3, Smad-1/-5/-8,
and Smad-4 signaling factors are expressed in ameloblastomas,
adenomatoid odontogenic tumors, and calcifying cystic
odontogenic tumors: An immunohistochemical study. J Oral
Pathol Med. 2013;42:415-23.
44) Harnet JC, Pedeutour F, Raybaud H, Ambrosetti D, Fabas T,
Lombardi T. Immunohistological features in adenomatoid
odontogenic tumor: Review of the literature and first expression
and mutational analysis of β-catenin in this unusual lesion of the
jaws. J Oral Maxillofac Surg. 2013;71:706-13.
45) Mosqueda-Taylor A, Carlos-Bregni R, Ramirez-Amador V,
Palma-Guzman JM, Esquivel-Bonilla D, Hernandez-Rojase LA.
Odontoameloblastoma. Clinico- pathologic study of three cases
and critical review of the literature. Oral Oncol. 2002;38:800-5.
46) Buchner A, Kaffe I, Vered M. Clinical and radiological profile
of ameloblastic fibro-odontoma: An update on an uncommon
odontogenic tumor based on a critical analysis of 114 cases. Head
Neck Pathol. 2013;7:54-63.
47) Buchner A, Vered M. Ameloblastic fibroma: A stage in the
development of a hamartomatous odontoma ora trueneoplasm?
Critical analysis of 162 previously reported cases plus 10 new
cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116:598-
606.
48) Chen Y, Li TJ, Gao Y, Yu SF. Ameloblastic fibroma and related
lesions: A clinicopathologic study with reference to their nature
and interrelationship. J Oral Pathol Med. 2005;34:588-95.
49) Philipsen HP, Reichart PA, Praetorius F. Mixed odontogenic
tumours and odontomas. Considerations on iInterrelationship.
Review of the literature and presentation of 134 new cases of
odontomas. Oral Oncol. 1997;33:86-99.
50) Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L,
Lim MS, Elenitoba-Johnson KS, Betz BL. Activating FGFR2-
RAS-BRAF mutations in ameloblastoma. Clin Cancer Res.
2014;20:5517-26.
51) Galvão CF, Gomes CC, Diniz MG, Vargas PA, de Paula
AM, Mosqueda-Taylor A, Loyola AM, Gomez RS. Loss of
heterozygosity (LOH) in tumour suppressor genes in benign
and malignant mixed odontogenic tumours. J Oral Pathol Med.
2012;41:389-93.
52) Mosqueda-Taylor A, Pires FR, Aguirre- Urízar JM, Carlos-
Bregni R, de la Piedra- Garza JM, Martínez-Conde R, Martínez-
Mata G, Carreño-Álvarez SJ, da Silveira HM, de Barros
Dias BS, de Almeida OP. Primordial odontogenic tumour:
Clinicopathological analysis of six cases of a previously
undescribed entity. Histopathology. 2014;65:606-12.
53) Slater LJ, Eftimie LF, Herford AS. Primordial odontogenic tumor:
Report of a case. J Oral Maxillofac Surg. 2016;74:547-51.
54) Buchner A, Akrish SJ, Vered M. Central dentinogenic ghost cell
tumor: An update on a rare aggressive odontogenic tumor. J Oral
Maxillofac Surg. 2016;74:307-14.
55) Gomes da Silva W, Ribeiro Bartholomeu dos Santos TC, Cabral
MG, Azevedo RS, Pires FR; Gomes da SW. Clinicopathologic
analysis and syndecan-1 and Ki-67 expression in calcifying cystic
odontogenic tumors, dentinogenic ghost cell tumor, and ghost
cell odontoge- nic carcinoma. Oral Surg Oral Med Oral Pathol
Oral Radiol. 2014;117:626-33.
56) Sun G, Huang X, Hu Q, Yang X, Tang E. The diagnosis and
treatment of dentinogenic ghost cell tumor. Int J Oral Maxillofac
Surg. 2009;38:1179-83.
57) El-Mofty SK. Fibro-osseous lesions of the craniofacial skeleton:
An update. Head Neck Pathol. 2014;8:432-44.
58) Dunlap CL. Odontogenic fibroma. Semin Diagn Pathol.
1999;16:293-6.
59) Allen CM, Hammond HL, Stimson PG. Central odontogenic
fibroma, WHO type. A report of three cases with an unusual
associated giant cell reaction. Oral Surg Oral Med Oral Pathol.
1992;73:62-6.
60) Shao Z, Liu B, Zhang W, Chen X. Synchronous occurrence of
odontogenic myxoma with multiple keratocystic odontogenic
tumors in nevoid basal cell carcinoma syndrome. J Craniofac
Surg. 2013;24:1840-2.
61) Wright JM, Odell E, Speight PM, Takata T. Odontogenic tumors,
WHO 2005: Where do we go from here? Head Neck Pathol
2014;8:373-82.
62) Shear M, Speight PM. Cysts of the oral and maxillofacial regions.
4th ed. Oxford: Blackwell Munksgaard; 2007.
63) Kramer IR, Pindborg JJ, Shear M. The WHO histological typing
of odontogenic tumours. A commentary on the second edition.
Cancer. 1992;70:2988-94.
64) Pavelic B, Levanat S, Crnić I, Kobler P, Anić I, Manojlović S,
Sutalo J. PTCH gene altered in dentigerous cysts. J Oral Pathol
Med. 2001;30:569-76.
65) Wakolbinger R, Beck-Mannagetta J. Long-term results after
treatment of extensive odontogenic cysts of the jaws: A review.
Clin Oral Investig. 2016;20:15-22.
66) Pogrel MA, Jordan RC. Marsupialization as a definitive
treatment for the odontogenic keratocyst. J Oral Maxillofac Surg.
2004;62:651-5.
67) Martin L, Speight PM. Mini-Symposium: Pathology of the jaws.
Odontogenic cysts. Diagnostic Histopathology. 2015;21:359-69.
68) Colmenero C, Patron M, Colmenero B. Odontogenic ghost cell
tumours: The neoplastic form of calcifying odontogenic cyst.
Craniomaxfac Surg. 1990;18:215-8.
69) Wright JM. The odontogenic keratocyst: Orthokeratinized
variant. Oral Surg Oral Med Oral Pathol. 1981;51:609e18.
70) Crowley TE, Kaugars GE, Gunsolley JC. Odontogenic keratocysts:
A clinical and histologic comparison of the parakeratin and
orthokeratin variants. J Oral Maxillofac Surg. 1992;50:22-6.
71) Fowler CB, Brannon RB, Kessler HP, Castle JT, Kahn MA.
Glandular odontogenic cyst: Analysis of 46 cases with special
emphasis on microscopic criteria for diagnosis. Head Neck
Pathol. 2011;5:364-75.
72) Bishop JA, Yonescu R, Batista D, Warnock GR, Westra
WH. Glandular odontogenic cysts (GOCs) lack MAML2
rearrangements: A finding to discredit the putative nature of
GOC aS precursor to central mucoepidermoid carcinoma. Head
Neck Pathol. 2014;8:287-90.
73) Tekkesin MS, Olgac V, Aksakalli N, Alatli C. Odontogenic and
nonodontogenic cysts in Istanbul: Analysis of 5088 cases. Head
Neck. 2012;34:852-5.
74) Philipsen HP, Reichart PA, Ogawa I, Suei Y, Takata T. The
inflammatory paradental cyst: A critical review of 342 cases from
a literature survey, including 17 new cases from the author’s files.
J Oral Pathol Med. 2004;33:147-55.
75) Maruyama S, Yamazaki M, Abé T, Babkair H, Cheng J, Saku
T. Paradental cyst is an inclusion cyst of the junctional/
sulcular epithelium of the gingiva: Histopathologic and
immunohistochemical confirmation for its pathogenesis. Oral
Surg Oral Med Oral Pathol Oral Radiol. 2015;120:227-37.